1 / 4

C sh RNA-LPS

Figure S1. a. H sh RNA-Unt. C sh RNA-Unt. H sh RNA-LPS. C sh RNA-LPS.

darrel-pitts
Télécharger la présentation

C sh RNA-LPS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Figure S1 a HshRNA-Unt CshRNA-Unt HshRNA-LPS CshRNA-LPS Fig. S1. (a). LPS-induced apoptosis in RAW264.7 cells. Reduced LPS-induced apoptosis in HuR knockdown stable clones. Red-TUNEL positive cells; Blue-DAPI; Purple-combined. CshRNA-Unt, Control shRNA treated RAW264.7 cells, no treatment; CshRNA-LPS, Control shRNA treated RAW264.7 cells, LPS treatment; HshRNA-Unt, HuR knock-down stable clones, no treatment; HshRNA-LPS, HuR knock-down stable clones, LPS treatment.

  2. Figure S1 b * # * % Apoptotic nuclei per HVF (Fig. S1. (b).Percent apoptotic cells averaged from ten high power visual fields (HVF). CshRNA-Unt, Control shRNA treated RAW264.7 cells, no treatment; CshRNA-LPS, Control shRNA treated RAW264.7 cells, LPS treatment; HshRNA-Unt, HuR knock-down stable clones, no treatment; HshRNA-LPS, HuR knock-down stable clones, LPS treatment. *P<0.01, untreated vs. LPS-treated groups; #P<0.01, between LPS-treated groups.

  3. mRNA expression vs. 18s (fold change vs. control) Figure S2 HuR * C IL-10 LPS LPS+IL10 Fig S2. Quantitative real-time PCR analysis of HuR mRNA expression in RAW264.7 cells. Cells were treated with LPS (10ng/ml) and/or IL-10 (10ng/ml) for 2h. IL-10 inhibited LPS-mediated increases in HuR mRNA expression (*P<0.01 vs. LPS-treated cells). Values are the means ± SE from triplicate experiments.

  4. Figure S3 CshRNA HshRNA Unt LPS Unt LPS mdm-2 β-actin TGF-β β-actin p53 β-actin Fig S3. p53, TGF-β and mdm-2 protein expression in RAW 264.7 cells. RAW264.7 cells were treated with LPS for 16hrs. Equal loading of proteins in each lane is shown by β-actin. CshRNA, Control shRNA treated RAW264.7 cells; HshRNA, HuR knock-down stable clones; Unt- untreated cells; LPS, LPS treated cells.

More Related